September 2, 2023 | 8:30 a.m. - 5:00 p.m. Pacific Time

Neuroscience Research Building at UCLA (Los Angeles, CA)

Hosted By
In Partnership with
Science in the City International

The Medical Cannabis Conference empowers clinicians to provide the best patient care through endocannabinoid system and cannabinoid medicine treatments.


Join the Society of Cannabis Clinicians esteemed faculty at its first national conference on September 2, 2023 at UCLA featuring world-renowned cannabis experts who have combined decades of experience using medical cannabis in their diverse patient populations. Topics which include the use of cannabis for various patient concerns (e.g., endometriosis, pediatrics, epilepsy, autism, addiction and hyperemesis, dementia and palliative care) on top of aspects of policy development for cannabis, grant funding for research, and social equity programs, will be covered in the first national conference for cannabis in medicine.



635 Charles E Young Drive South
Los Angeles, CA 90095

Conference Activities

9:00 AM

Genester Wilson-King, MD: Cannabis and Endometriosis: It Should be a Treatment Option Now

10:00 AM

Patricia Frye, MD: Exploring the Potential Benefits of Cannabis in Autism Spectrum Disorders

11:00 am

Bonni Goldstein, MD: Clinical Effects of Two Important Cannabinoids: CBDV and CBG

12:00 pm

Tim Fong, MD: 2023 Updates to Management of Cannabis Use Disorder

12:30 pm


1:15 pm

Sherry Yafai, MD: Dementia and Palliative Care: Where and how can Cannabis be used?

2:15 pm

California Department of Cannabis Control

2:45 pm

Reji Varghese, MBC

3:15 pm

Dr. Imani Brown: The Importance of Social Equity in the Licensed Cannabis Market

3:45 pm

Roundtable Discussion

4:15 pm


4:30 pm

Stephen Robinson, MD, MPH: Closing Remarks

5:00 pm

Program Ends

Networking & Sponsorship Booth Exhibition

6:00 - 8:00 pm

Happy Hour at SLS Hotel
hosted by MedinaCBD

Expert Speakers

Untitled design (25)

Sherry Yafai, MD

Cannabis Specialist and Board-Certified Emergency Medicine physician

Genester Wilson-King, MD FACOG

Board-Certified obstetrician and gynecologist and Fellow of the American College of OB/Gyn

Timothy W. Fong, MD

Board-certified in Adult and Addiction Psychiatry and part of the faculty leadership of the UCLA Cannabis Research Initiative

Bonni Goldstein, MD

Medical Director of Canna-Centers Wellness & Education

Patricia Frye, MD

Affiliate Associate Professor University of Maryland School of Pharmacy in Cannabis Science and Therapeutics

Imani Brown, PhD

Social Equity Program Director for the Department of Cannabis Regulation

Dilara K. Üsküp, PhD​

Assistant Professor in Internal Medicine at Charles R. Drew University of Medicine and Sciences​

Reji T. Varghese, MBC​

Interim Executive Director at Medical Board of California​

Stephen Robinson, MD, MPH​

President, Society for Cannabis Clinicians​

At the conclusion of this activity, the attendees will be able to:

  1. Recommend cannabis appropriately as a treatment method for various medical issues
  2. Define cannabis use disorder, help prevent it, and manage patients appropriately who have it
  3. Design practice policies and procedures to stay in compliance with all county and state requirements
  4. Practice social equity in dealing with patients in the cannabis market

Those who attend the conference will also earn CME credits for their practice.

ACCME Joint Provider Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Saint John’s Health Center and Society of Cannabis Clinicians. Saint John’s Health Center is accredited by the ACCME to provide continuing medical education for physicians.

AMA Credit Designation Statement:

Saint John’s Health Center designates this Live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Be at the forefront of medical innovation and responsible policy making and take patient care to the next level.

Skip to content